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Dear Editor:
Ulcerate colitis (UC), the main type of inflammatory bowel
disease (IBD), is an unexplained immune-mediated intestinal
mucosal inflammation with higher cancer risk. Because of an
interaction between inflammation and coagulation in the dis-
ease progression, hypercoagulative state is often seen in pa-
tients of UC. Endothelial cell damage plays an important role
in the activation of coagulation system in patients with UC,
while protein C (PC) system, a well-characterized anticoagu-
lant system located on the vascular endothelial cell surface,
which consists of protein S (PS), endothelial cell protein C
recep to r (EPCR) , PC, pro te in C inh ib i to r, and
thrombomodulin (TM), is a mediator of endothelial function.
Recent studies indicated that PC system plays an important
role in regulating intestinal homeostasis both in human intes-
tinal microvascular endothelial cells and animal models of
colitis. Therefore, we speculate that the imbalance of PC sys-
tem may be one of the pathogenesis of UC patients. Our in
vivo study verified that the degree of inflammation was neg-
atively correlated with the PC activity, and mouse colonic
macrophages and mucosa microvascular endothelial cells are
suggested as the major mediators involved. Until today, it is
unclear why PC system changed, and how macrophages and
mucosa microvascular endothelial cells interact with each oth-
er in UC pathology, so it is important to investigate the chang-
es and mechanisms of PC system, and to find new drug target.
Further research in vitro revealed that TNF-α and IL-6 levels
were increased in the supernatant of macrophages from
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dextran sulfate sodium (DSS) mice colonic tissue, and
these conditions were only seen in CD14+CD64+ subtype
macrophages. In addition, after incubation of TNF-α or
IL-6 with colonic mucosal microvascular endothelial cells,
the activity of PC system was inhibited, manifested as
decreased APC activity, and downregulated expression of
EPCR. Furthermore, β-arrestin-pJNK MAPK expressions
were upregulated by real-time PCR and Western blot. Tak-
en together into account, due to complex UC mechanism,
its pathogenesis is unclear, and there is little research
about colonic mucosal microvascular, especially the study
for PC system changes in the pathogenesis of UC is rare.
In our study, we found that in DSS-induced mouse colitis,
colonic CD14+CD64+ macrophages produced more inflam-
matory cytokines, which result in inhibited PC pathway
via mucosal microvascular endothelial cells, and β-
arrestin-pJNK MAPK signal pathway may involved.
Therefore, enhancing the activity of PC system provides
a major theoretical and clinical significance to find new
drug target for the treatment of UC.
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